Revenue Summary of Viveve Medical, Inc.

Viveve Medical, Inc.'s latest annual revenue in 2021 was 6.42 Million USD , up 17.28% from previous year.
Viveve Medical, Inc.'s latest quarterly revenue in 2022 Q3 was 1.68 Million USD , down -6.18% from previous quarter.
Viveve Medical, Inc. reported a annual revenue of 5.47 Million USD in annual revenue 2020, down -16.57% from previous year.
Viveve Medical, Inc. reported a annual revenue of 6.56 Million USD in annual revenue 2019, down -64.54% from previous year.
Viveve Medical, Inc. reported a quarterly revenue of 1.79 Million USD for 2022 Q2, up 9.38% from previous quarter.
Viveve Medical, Inc. reported a quarterly revenue of 1.64 Million USD for 2022 Q1, down -3.81% from previous quarter.

Annual Revenue Chart of Viveve Medical, Inc. (2021 - 1990)

Historical Annual Revenue of Viveve Medical, Inc. (2021 - 1990)

Year	Revenue	Revenue Growth
2021	6.42 Million USD	17.28%
2020	5.47 Million USD	-16.57%
2019	6.56 Million USD	-64.54%
2018	18.51 Million USD	21.12%
2017	15.28 Million USD	114.09%
2016	7.14 Million USD	393.5%
2015	1.44 Million USD	1507.78%
2014	90 Thousand USD	-92.94%
2013	1.27 Million USD	17.96%
2012	1.08 Million USD	60.95%
2011	671 Thousand USD	-82.84%
2010	3.91 Million USD	-17.0%
2009	4.71 Million USD	-11.61%
2008	5.33 Million USD	-11.23%
2007	6 Million USD	-15.98%
2006	7.14 Million USD	-6.42%
2005	7.63 Million USD	0.83%
2004	7.57 Million USD	-9.13%
2003	8.33 Million USD	-5.7%
2002	8.83 Million USD	-9.63%
2001	9.78 Million USD	-4.49%
2000	10.24 Million USD	-12.0%
1999	11.63 Million USD	104.14%
1998	5.7 Million USD	-35.96%
1997	8.9 Million USD	-25.21%
1996	11.9 Million USD	-10.53%
1995	13.3 Million USD	155.77%
1994	5.2 Million USD	57.58%
1993	3.3 Million USD	37.5%
1992	2.4 Million USD	2300.0%
1991	100 Thousand USD	0.0%
1990	100 Thousand USD	0.0%

Year	Revenue	Revenue Growth
2022 Q3	1.68 Million USD	-6.18%
2022 Q2	1.79 Million USD	9.38%
2022 Q1	1.64 Million USD	-3.81%
2021 Q2	1.65 Million USD	14.07%
2021 Q3	1.61 Million USD	-2.3%
2021 Q4	1.7 Million USD	5.57%
2021 FY	6.42 Million USD	17.28%
2021 Q1	1.45 Million USD	-25.53%
2020 Q3	1.52 Million USD	116.48%
2020 Q1	1.3 Million USD	-10.13%
2020 Q2	704 Thousand USD	-46.01%
2020 Q4	1.94 Million USD	27.76%
2020 FY	5.47 Million USD	-16.57%
2019 Q3	1.05 Million USD	0.0%
2019 Q1	3.01 Million USD	-32.65%
2019 Q4	1.45 Million USD	37.93%
2019 Q2	1.05 Million USD	-65.07%
2019 FY	6.56 Million USD	-64.54%
2018 Q3	4.82 Million USD	-12.74%
2018 Q1	3.69 Million USD	-27.48%
2018 Q2	5.52 Million USD	49.36%
2018 FY	18.51 Million USD	21.12%
2018 Q4	4.47 Million USD	-7.24%
2017 Q1	3.04 Million USD	24.02%
2017 FY	15.28 Million USD	114.09%
2017 Q4	5.1 Million USD	25.33%
2017 Q3	4.07 Million USD	32.31%
2017 Q2	3.07 Million USD	1.15%
2016 Q3	1.84 Million USD	18.83%
2016 Q4	2.45 Million USD	32.61%
2016 Q1	1.28 Million USD	70.74%
2016 Q2	1.55 Million USD	21.18%
2016 FY	7.14 Million USD	393.5%
2015 Q2	73 Thousand USD	92.11%
2015 Q3	584 Thousand USD	700.0%
2015 Q1	38 Thousand USD	48.87%
2015 FY	1.44 Million USD	1507.78%
2015 Q4	752 Thousand USD	28.77%
2014 Q3	17.18 Thousand USD	-76.47%
2014 FY	90 Thousand USD	-92.94%
2014 Q1	54 Thousand USD	-73.66%
2014 Q2	73 Thousand USD	35.19%
2014 Q4	25.52 Thousand USD	48.57%
2013 Q3	348 Thousand USD	-6.45%
2013 Q1	348 Thousand USD	-28.25%
2013 FY	1.27 Million USD	17.96%
2013 Q4	205 Thousand USD	-41.09%
2013 Q2	372 Thousand USD	6.9%
2012 Q3	212 Thousand USD	-41.6%
2012 Q2	363 Thousand USD	1715.0%
2012 Q1	20 Thousand USD	-89.42%
2012 FY	1.08 Million USD	60.95%
2012 Q4	485 Thousand USD	128.77%
2011 Q4	189 Thousand USD	600.0%
2011 FY	671 Thousand USD	-82.84%
2011 Q2	398 Thousand USD	598.25%
2011 Q1	57 Thousand USD	-93.92%
2011 Q3	27 Thousand USD	-93.22%
2010 FY	3.91 Million USD	-17.0%
2010 Q3	892 Thousand USD	-12.46%
2010 Q1	1.06 Million USD	17.87%
2010 Q2	1.01 Million USD	-4.05%
2010 Q4	937 Thousand USD	5.04%
2009 Q3	1.02 Million USD	-16.15%
2009 Q1	1.56 Million USD	24.96%
2009 Q4	901 Thousand USD	-11.93%
2009 FY	4.71 Million USD	-11.61%
2009 Q2	1.22 Million USD	-22.14%
2008 Q1	1.16 Million USD	-6.41%
2008 FY	5.33 Million USD	-11.23%
2008 Q4	1.25 Million USD	-21.53%
2008 Q3	1.59 Million USD	21.98%
2008 Q2	1.31 Million USD	12.16%
2007 FY	6 Million USD	-15.98%
2007 Q4	1.24 Million USD	-6.24%
2007 Q2	1.93 Million USD	29.4%
2007 Q1	1.49 Million USD	-14.54%
2007 Q3	1.33 Million USD	-31.11%
2006 Q2	1.94 Million USD	2.86%
2006 FY	7.14 Million USD	-6.42%
2006 Q1	1.88 Million USD	4.31%
2006 Q4	1.74 Million USD	11.49%
2006 Q3	1.56 Million USD	-19.35%
2005 FY	7.63 Million USD	0.83%
2005 Q4	1.81 Million USD	-4.68%
2005 Q3	1.9 Million USD	-4.14%
2005 Q1	1.94 Million USD	-14.1%
2005 Q2	1.98 Million USD	2.01%
2004 Q3	1.6 Million USD	-10.58%
2004 Q2	1.79 Million USD	-5.92%
2004 Q1	1.9 Million USD	-18.24%
2004 FY	7.57 Million USD	-9.13%
2004 Q4	2.26 Million USD	40.85%
2003 Q2	2.01 Million USD	15.97%
2003 FY	8.33 Million USD	-5.7%
2003 Q3	2.25 Million USD	12.08%
2003 Q4	2.33 Million USD	3.59%
2003 Q1	1.73 Million USD	-22.73%
2002 Q4	2.24 Million USD	12.48%
2002 FY	8.83 Million USD	-9.63%
2002 Q3	1.99 Million USD	-8.44%
2002 Q2	2.17 Million USD	-9.96%
2002 Q1	2.42 Million USD	-3.24%
2001 Q4	2.5 Million USD	6.11%
2001 Q3	2.35 Million USD	-8.68%
2001 Q2	2.58 Million USD	10.25%
2001 Q1	2.34 Million USD	-1.18%
2001 FY	9.78 Million USD	-4.49%
2000 Q1	1.74 Million USD	-36.33%
2000 Q2	3.58 Million USD	105.51%
2000 Q3	2.54 Million USD	-28.8%
2000 Q4	2.36 Million USD	-7.06%
2000 FY	10.24 Million USD	-12.0%
1999 Q4	2.73 Million USD	9.44%
1999 Q3	2.5 Million USD	-28.57%
1999 Q2	3.5 Million USD	25.0%
1999 Q1	2.8 Million USD	12.0%
1999 FY	11.63 Million USD	104.14%
1998 Q1	900 Thousand USD	-55.0%
1998 Q3	1.6 Million USD	128.57%
1998 Q4	2.5 Million USD	56.25%
1998 FY	5.7 Million USD	-35.96%
1998 Q2	700 Thousand USD	-22.22%
1997 Q2	3.4 Million USD	112.5%
1997 Q3	1.9 Million USD	-44.12%
1997 FY	8.9 Million USD	-25.21%
1997 Q1	1.6 Million USD	-48.39%
1997 Q4	2 Million USD	5.26%
1996 Q1	4.8 Million USD	-35.14%
1996 Q4	3.1 Million USD	24.0%
1996 Q3	2.5 Million USD	78.57%
1996 Q2	1.4 Million USD	-70.83%
1996 FY	11.9 Million USD	-10.53%
1995 Q2	1.5 Million USD	-48.28%
1995 Q3	1.6 Million USD	6.67%
1995 Q4	7.4 Million USD	362.5%
1995 Q1	2.9 Million USD	61.11%
1995 FY	13.3 Million USD	155.77%
1994 Q1	1.4 Million USD	16.67%
1994 FY	5.2 Million USD	57.58%
1994 Q3	1 Million USD	0.0%
1994 Q4	1.8 Million USD	80.0%
1994 Q2	1 Million USD	-28.57%
1993 Q4	1.2 Million USD	71.43%
1993 FY	3.3 Million USD	37.5%
1993 Q1	800 Thousand USD	-11.11%
1993 Q2	600 Thousand USD	-25.0%
1993 Q3	700 Thousand USD	16.67%
1992 Q4	900 Thousand USD	28.57%
1992 Q1	200 Thousand USD	0.0%
1992 Q3	700 Thousand USD	16.67%
1992 Q2	600 Thousand USD	200.0%
1992 FY	2.4 Million USD	2300.0%
1991 Q4	- USD	-100.0%
1991 Q2	100 Thousand USD	0.0%
1991 Q3	100 Thousand USD	0.0%
1991 Q1	100 Thousand USD	0.0%
1991 FY	100 Thousand USD	0.0%
1990 FY	100 Thousand USD	0.0%
1990 Q3	100 Thousand USD	0.0%
1990 Q2	100 Thousand USD	0.0%
1990 Q1	100 Thousand USD	0.0%
1990 Q4	- USD	-100.0%

Peer Revenue Comparison of Viveve Medical, Inc.

Name	Revenue	Revenue Difference
Acutus Medical, Inc.	7.16 Million USD	10.302%
Biotricity, Inc.	12.06 Million USD	46.731%
Cell MedX Corp.	- USD	-Infinity%
Dynatronics Corporation	32.53 Million USD	80.248%
Nemaura Medical Inc.	77.04 Thousand USD	-8240.688%
PetVivo Holdings, Inc.	968.7 Thousand USD	-563.359%
RetinalGenix Technologies Inc.	- USD	-Infinity%
Sonendo, Inc.	43.86 Million USD	85.351%
Telesis Bio, Inc.	27.5 Million USD	76.64%
Talis Biomedical Corporation	412 Thousand USD	-1459.709%

Global Stocks Search

Viveve Medical, Inc. (VIVE)

Revenue Summary of Viveve Medical, Inc.

Annual Revenue Chart of Viveve Medical, Inc. (2021 - 1990)

Historical Annual Revenue of Viveve Medical, Inc. (2021 - 1990)

Peer Revenue Comparison of Viveve Medical, Inc.